Clinical trials
Phase 1 Carcinoma trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2015 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blueprint Medicines Corporation | 2 |
| AstraZeneca | 1 |
| Eisai Co., Ltd. | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 5 |
| Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Bronchial Neoplasms | 2 |
| Carcinoma, Bronchogenic | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Lung Diseases | 2 |
| Lung Neoplasms | 2 |
| Neoplasms by Histologic Type | 2 |
| Neoplasms by Site | 2 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.